Organization Overview
Alternative names
abemaciclib (verzenio) (2 trials)
acetylcysteine (mucomyst) (2 trials)
acetylsalicylic acid (aspirin) (1 trial)
arsenic trioxide (trisenox) (1 trial)
bevacizumab (avastin) (2 trials)
cabozantinib (cometriq) (3 trials)
capecitabine (xeloda) (2 trials)
carboplatin (paraplatin) (3 trials)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
disulfiram (antabuse) (2 trials)
docetaxel (taxotere) (4 trials)
doxorubicin (Doxil) (2 trials)
eflornithine (ornidyl) (1 trial)
fluorouracil (efudex) (1 trial)
gemcitabine (gemzar) (1 trial)
glasdegib (Daurismo) (1 trial)
irinotecan (Camptosar) (3 trials)
lovastatin (mevacor) (1 trial)
methazolamide (neptazane) (1 trial)
Aberrant Crypt Foci (Phase 2)
Adenocarcinoma (Phase 2)
Adenomatous Polyps (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Cognitive Dysfunction (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hepatitis (Phase 2)
Hepatitis C (Phase 2)
Infections (Phase 2)
Keratosis (Phase 2)
Keratosis, Actinic (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Melanoma (Phase 2)
Mesothelioma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Precancerous Conditions (Phase 2)
Preleukemia (Phase 2)
Prostatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Sarcoma (Phase 2)
Skin Neoplasms (Phase 2)
Stomach Neoplasms (Phase 2)
Tobacco Use Disorder (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
